Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 4/2009

01-04-2009 | original article

Prediction of Anastomotic Leakage After Pancreatic Head Resections by Dynamic Magnetic Resonance Imaging (dMRI)

Authors: Dietmar J. Dinter, Niloufar Aramin, Christel Weiss, Christoph Singer, Gerald Weisser, Stefan O. Schoenberg, Stefan Post, Marco Niedergethmann

Published in: Journal of Gastrointestinal Surgery | Issue 4/2009

Login to get access

Abstract

Purpose

The texture of the pancreatic tissue is a main risk factor for leakage after pancreaticojejunostomy and can be differentiated using dynamic contrast enhanced magnetic resonance imaging (dMRI). In order to identify risk factors and to assess the role of pancreatic dMRI, a cohort of patients was retrospectively reviewed.

Patients and methods

One hundred seven consecutive patients were identified in the departmental database and examined by means of a standardized dMRI protocol using a 1.5-T MRI system. Signal intensity (SI) measurements (aorta, body of the pancreas, muscle tissue) were performed in the axial T1-weighted sequences before and after 25 and 60 s after i.v. application of gadolinium–diethylenetriaminepentaacetic acid. For all patients with a standardized contrast medium curve in the aorta (n = 72), a muscle-normalized signal intensity curve (SIC) with SIratio was calculated. SIratios were classified in two groups: rapid increase (SIratio ≥ 1.1, early arterial value > portal-venous value, “soft” pancreas) and delayed increase (SIratio <1.1, “firm” or “hard” pancreas). All patients received pancreatic head resection with a duct-to-mucosa pancreaticojejunostomy. The dMRI data was correlated with prospectively acquired clinical data.

Results

Leakage of the pancreaticojejunostomy occurred more frequently (12/37 vs. two of 35, 32% vs. 6%, p = 0.006) in patients with a rapid increase and an SIratio ≥ 1.1 (“soft” pancreas, n = 37) compared to those with delayed perfusion (SIratio <1.1, “hard” pancreas, n = 35). The more severe type B and C anastomotic leakages occurred only in the group of patients with SIratio ≥ 1.1. Patients with a rapid increase had significantly better preoperative American Society of Anesthesiologists staging, lower carbohydrate antigen 19-9 values, and smaller tumor sizes. Most of them had not only benign tumors but also longer postoperative hospital stay, in comparison to patients with delayed perfusion (SIratio <1.1). Multivariate analysis revealed SIratio of ≥1.1 to be the only preoperative parameter predicting leakage significantly with an odds ratio of 7.9.

Conclusion

dMRI with SIratio calculation provided reliable information for the prediction of pancreatic texture. Patients with a SIratio ≥ 1.1 had a 7.9-fold increased risk of anastomotic leakage and a prolonged hospital stay. SIC with measurements of SIratio in dMRI could therefore define patients at risk for anastomotic leakage.
Literature
1.
go back to reference Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003;27(3):324–329. doi:10.1007/s00268-002-6659-z.PubMedCrossRef Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003;27(3):324–329. doi:10.​1007/​s00268-002-6659-z.PubMedCrossRef
5.
go back to reference DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006;244(6):931–937. doi:10.1097/01.sla.0000246856.03918.9a, discussion 937–939.PubMedCrossRef DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006;244(6):931–937. doi:10.​1097/​01.​sla.​0000246856.​03918.​9a, discussion 937–939.PubMedCrossRef
6.
go back to reference Callery MP, Pratt WB, Vollmer CM Jr. Prevention and management of pancreatic fistula. J Gastrointest Surg 2008 (in press). Callery MP, Pratt WB, Vollmer CM Jr. Prevention and management of pancreatic fistula. J Gastrointest Surg 2008 (in press).
7.
go back to reference Niedergethmann M, Farag Soliman M, Post S. Postoperative complications of pancreatic cancer surgery. Minerva Chir 2004;59(2):175–183.PubMed Niedergethmann M, Farag Soliman M, Post S. Postoperative complications of pancreatic cancer surgery. Minerva Chir 2004;59(2):175–183.PubMed
9.
go back to reference Reid-Lombardo KM, Farnell MB, Crippa S, Barnett M, Maupin G, Bassi C, et al. Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. J Gastrointest Surg 2007;11(11):1451–1458. doi:10.1007/s11605-007-0270-4, discussion 1459.PubMedCrossRef Reid-Lombardo KM, Farnell MB, Crippa S, Barnett M, Maupin G, Bassi C, et al. Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. J Gastrointest Surg 2007;11(11):1451–1458. doi:10.​1007/​s11605-007-0270-4, discussion 1459.PubMedCrossRef
12.
go back to reference Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT. Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 2005;11(16):2456–2461.PubMed Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT. Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 2005;11(16):2456–2461.PubMed
13.
go back to reference Bartoli FG, Arnone GB, Ravera G, Bachi V. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 1991;11(5):1831–1848.PubMed Bartoli FG, Arnone GB, Ravera G, Bachi V. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 1991;11(5):1831–1848.PubMed
15.
go back to reference Sittek H, Heuck AF, Folsing C, Gieseke J, Reiser M. Static and dynamic MR tomography of the pancreas: contrast media kinetics of the normal pancreatic parenchyma in pancreatic carcinoma and chronic pancreatitis. Rofo 1995;162(5):396–403.PubMed Sittek H, Heuck AF, Folsing C, Gieseke J, Reiser M. Static and dynamic MR tomography of the pancreas: contrast media kinetics of the normal pancreatic parenchyma in pancreatic carcinoma and chronic pancreatitis. Rofo 1995;162(5):396–403.PubMed
18.
go back to reference Niedergethmann M, Shang E, Farag Soliman M, Saar J, Berisha S, Willeke F, et al. Early and enduring nutritional and functional results of pylorus preservation vs classic Whipple procedure for pancreatic cancer. Langenbecks Arch Surg 2006;391(3):195–202. doi:10.1007/s00423-005-0015-3.PubMedCrossRef Niedergethmann M, Shang E, Farag Soliman M, Saar J, Berisha S, Willeke F, et al. Early and enduring nutritional and functional results of pylorus preservation vs classic Whipple procedure for pancreatic cancer. Langenbecks Arch Surg 2006;391(3):195–202. doi:10.​1007/​s00423-005-0015-3.PubMedCrossRef
20.
go back to reference Bassi C, Butturini G, Molinari E, Mascetta G, Salvia R, Falconi M, et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg 2004;21(1):54–59. doi:10.1159/000075943.PubMedCrossRef Bassi C, Butturini G, Molinari E, Mascetta G, Salvia R, Falconi M, et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg 2004;21(1):54–59. doi:10.​1159/​000075943.PubMedCrossRef
21.
go back to reference Yeo CJ. Management of complications following pancreaticoduodenectomy. Surg Clin North Am 1995;75(5):913–924.PubMed Yeo CJ. Management of complications following pancreaticoduodenectomy. Surg Clin North Am 1995;75(5):913–924.PubMed
24.
go back to reference van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 1997;185(1):18–24.PubMed van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 1997;185(1):18–24.PubMed
26.
go back to reference Gaa J, Wendl K, Tesdal IK, Meier-Willersen HJ, Lehmann KJ, Bohm C, et al. Combined use of MRI and MR cholangiopancreatography and contrast enhanced dual phase 3-D MR angiography in diagnosis of pancreatic tumors: initial clinical results. Rofo 1999;170(6):528–533.PubMed Gaa J, Wendl K, Tesdal IK, Meier-Willersen HJ, Lehmann KJ, Bohm C, et al. Combined use of MRI and MR cholangiopancreatography and contrast enhanced dual phase 3-D MR angiography in diagnosis of pancreatic tumors: initial clinical results. Rofo 1999;170(6):528–533.PubMed
27.
go back to reference Sahani DV, Shah ZK, Catalano OA, Boland GW, Brugge WR. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 2008;23(1):23–33.PubMed Sahani DV, Shah ZK, Catalano OA, Boland GW, Brugge WR. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 2008;23(1):23–33.PubMed
31.
go back to reference Coenegrachts K, Van Steenbergen W, De Keyzer F, Vanbeckevoort D, Bielen D, Chen F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004;20(6):990–997. doi:10.1002/jmri.20212.PubMedCrossRef Coenegrachts K, Van Steenbergen W, De Keyzer F, Vanbeckevoort D, Bielen D, Chen F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004;20(6):990–997. doi:10.​1002/​jmri.​20212.PubMedCrossRef
32.
go back to reference Tajima Y, Kuroki T, Tsutsumi R, Fukuda K, Kitasato A, Adachi T, et al. Risk factors for pancreatic anastomotic leakage: the significance of preoperative dynamic magnetic resonance imaging of the pancreas as a predictor of leakage. J Am Coll Surg 2006;202(5):723–731. doi:10.1016/j.jamcollsurg.2006.01.008.PubMedCrossRef Tajima Y, Kuroki T, Tsutsumi R, Fukuda K, Kitasato A, Adachi T, et al. Risk factors for pancreatic anastomotic leakage: the significance of preoperative dynamic magnetic resonance imaging of the pancreas as a predictor of leakage. J Am Coll Surg 2006;202(5):723–731. doi:10.​1016/​j.​jamcollsurg.​2006.​01.​008.PubMedCrossRef
33.
go back to reference Tajima Y, Matsuzaki S, Furui J, Isomoto I, Hayashi K, Kanematsu T. Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 2004;91(5):595–600. doi:10.1002/bjs.4461.PubMedCrossRef Tajima Y, Matsuzaki S, Furui J, Isomoto I, Hayashi K, Kanematsu T. Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 2004;91(5):595–600. doi:10.​1002/​bjs.​4461.PubMedCrossRef
34.
go back to reference Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers—initial results. Radiology 2008;247(1):115–121.PubMedCrossRef Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers—initial results. Radiology 2008;247(1):115–121.PubMedCrossRef
35.
go back to reference Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005;53(2):249–255. doi:10.1002/mrm.20374.PubMedCrossRef Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005;53(2):249–255. doi:10.​1002/​mrm.​20374.PubMedCrossRef
38.
go back to reference Fang WL, Su CH, Shyr YM, Chen TH, Lee RC, Tai LC, et al. Functional and morphological changes in pancreatic remnant after pancreaticoduodenectomy. Pancreas 2007;35(4):361–365.PubMedCrossRef Fang WL, Su CH, Shyr YM, Chen TH, Lee RC, Tai LC, et al. Functional and morphological changes in pancreatic remnant after pancreaticoduodenectomy. Pancreas 2007;35(4):361–365.PubMedCrossRef
39.
go back to reference Hayashibe A, Kameyama M. The clinical results of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy in consecutive 55 cases. Pancreas 2007;35(3):273–275.PubMedCrossRef Hayashibe A, Kameyama M. The clinical results of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy in consecutive 55 cases. Pancreas 2007;35(3):273–275.PubMedCrossRef
41.
42.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000;232(3):419–429. doi:10.1097/00000658-200009000-00014.PubMedCrossRef Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000;232(3):419–429. doi:10.​1097/​00000658-200009000-00014.PubMedCrossRef
43.
go back to reference Fujino Y, Suzuki Y, Ajiki T, Tanioka Y, Ku Y, Kuroda Y. Risk factors influencing pancreatic leakage and the mortality after pancreaticoduodenectomy in a medium-volume hospital. Hepatogastroenterology 2002;49(46):1124–1129.PubMed Fujino Y, Suzuki Y, Ajiki T, Tanioka Y, Ku Y, Kuroda Y. Risk factors influencing pancreatic leakage and the mortality after pancreaticoduodenectomy in a medium-volume hospital. Hepatogastroenterology 2002;49(46):1124–1129.PubMed
Metadata
Title
Prediction of Anastomotic Leakage After Pancreatic Head Resections by Dynamic Magnetic Resonance Imaging (dMRI)
Authors
Dietmar J. Dinter
Niloufar Aramin
Christel Weiss
Christoph Singer
Gerald Weisser
Stefan O. Schoenberg
Stefan Post
Marco Niedergethmann
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 4/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-008-0765-7

Other articles of this Issue 4/2009

Journal of Gastrointestinal Surgery 4/2009 Go to the issue